[Rotavirus vaccination in Europe in 2010].

Abstract

The important burden of rotavirus infections in infants largely justifies vaccine prevention. Two attenuated oral vaccines were licensed in Europe in 2006 and have proven effective against severe rotavirus gastroenteritis in infants, yet few countries have implemented vaccination. This hesitation may be related to a very low risk of intussusception in vaccinees, but is mainly due to national differences in cost-effectiveness.

• Authors: Emmanuel Grimprel
• Journal: Bulletin de l'Academie nationale de medecine (Bull Acad Natl Med) Vol. 194 Issue 8 Pg. 1451-62; discussion 1462-4 (Nov 2010) ISSN: 0001-4079 [Print] Netherlands
• Vernacular Title: La vaccination rotavirus en Europe en 2010.
• PMID: 22046709 (Publication Type: Evaluation Study, Journal Article, Review)

Chemical References

• Rotavirus Vaccines

Topics

• Europe (epidemiology)
• Humans
• Infant
• Infant Mortality (trends)
• Infant, Newborn
• Rotavirus (immunology)
• Rotavirus Infections (epidemiology, immunology, mortality, prevention & control)
• Rotavirus Vaccines (adverse effects, therapeutic use)
• Time Factors
• Vaccination (adverse effects, economics, methods, statistics & numerical data)